Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORWARDS-1 acute baclofen safety study in methadone-maintained adults with opioid dependence
ISRCTN61480522Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jan 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial in opioid use disorder (OUD) comparing Baclofen with Placebo (2 arms). Primary endpoints: Maximum safe baclofen dose with target DLT probability, Dose-limiting toxicity composite and 5 more. Started Jan 2022; status: completed.
02
Drugs
baclofen
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ISRCTN61480522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61480522.